Clinical trial
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced…
NCT00283439 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00283439 |
|---|---|
| Title | A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma |
| Official title | An Open Label Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 for Treatment of Severe Thrombocytopenia Due to Multi-Cycle Chemotherapy in Adult Subjects With Lymphoma. |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Chemotherapy-Induced Thrombocytopenia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Cancer, Oncology, Thrombocytopenia |
| Intervention type | Biological |
| Interventions | AMG 531 |
| Enrollment | 39 |
| Start date | Oct 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jan 30, 2006 |
| Last update posted | Jun 20, 2011 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: